SkinHealth Systems Inc. Capitalized Computer Software, Amortization
SkinHealth Systems Inc. (SKIN) reported Capitalized Computer Software, Amortization of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CapitalizedComputerSoftwareAmortization1 · last filed 2023-03-01
- SkinHealth Systems Inc. capitalized computer software, amortization for the quarter ending 2022-12-31 was -$1.46M.
- SkinHealth Systems Inc. capitalized computer software, amortization for the quarter ending 2022-09-30 was $560.00K, a 69.70% increase year-over-year.
- SkinHealth Systems Inc. capitalized computer software, amortization for the quarter ending 2022-06-30 was $499.00K, a 20.29% decline year-over-year.
- SkinHealth Systems Inc. capitalized computer software, amortization for the quarter ending 2022-03-31 was $404.00K.
- SkinHealth Systems Inc. capitalized computer software, amortization for fiscal 2022 was $0.00.
- SkinHealth Systems Inc. capitalized computer software, amortization for fiscal 2021 was $0.00.
- SkinHealth Systems Inc. capitalized computer software, amortization for fiscal 2020 was $0.00.
| Period end | Capitalized Computer Software, Amortization 3 month | Capitalized Computer Software, Amortization 6 month | Capitalized Computer Software, Amortization 9 month | Capitalized Computer Software, Amortization 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$903.00K derived: sum of 2 quarters · filed 2023-03-01 | -$404.00K derived: sum of 3 quarters · filed 2023-03-01 | $0.00 10-K · filed 2023-03-01 |
| 2022-09-30 | $560.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.06M derived: sum of 2 quarters · filed 2022-11-09 | $1.46M 10-Q · filed 2022-11-09 | $507.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2022-06-30 | $499.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $903.00K 10-Q · filed 2022-08-09 | -$53.00K derived: sum of 3 quarters · filed 2023-03-01 | $277.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2022-03-31 | $404.00K 10-Q · filed 2022-05-10 | -$552.00K derived: sum of 2 quarters · filed 2023-03-01 | -$222.00K derived: sum of 3 quarters · filed 2023-03-01 | $404.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-12-31 | -$956.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$626.00K derived: sum of 2 quarters · filed 2023-03-01 | $0.00 derived: sum of 3 quarters · filed 2023-03-01 | $0.00 10-K · filed 2023-03-01 |
| 2021-09-30 | $330.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $956.00K derived: sum of 2 quarters · filed 2022-11-09 | $956.00K 10-Q · filed 2022-11-09 | $154.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $626.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $626.00K 10-Q · filed 2022-08-09 | -$176.00K derived: sum of 3 quarters · filed 2023-03-01 | $277.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | -$802.00K derived: sum of 2 quarters · filed 2023-03-01 | -$349.00K derived: sum of 3 quarters · filed 2023-03-01 | |
| 2020-12-31 | -$802.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$349.00K derived: sum of 2 quarters · filed 2023-03-01 | $0.00 10-K · filed 2023-03-01 | |
| 2020-09-30 | $453.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $802.00K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $349.00K 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |